Total Knee Arthroplasty. Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention 1: Control group: The patients in the control group will receive only normal saline. Intervention 2: Intervention group: The patients in the intervention group will receive the first asco
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Candidates of total knee arthroplasty patients who provide written informed consent to be included in this study
Exclusion criteria
Exclusion criteria: history of thromboembolic events like deep vein thrombosis or pulmonary embolism history of cardiovascular disease like myocardial infarction or atrial fibrillation being in pregnancy or in the lactation period drug abusers or alcoholics severe renal dysfunction severe infection the preoperative hemoglobin less than 10 g/dL diagnosis of inflammatory arthritis like rheumatoid arthritis, pigmented villonodular synovitis and etc clotting disorders including abnormal PT, PTT or INR
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total blood loss. Timepoint: Before intervention, 24h after intervention. Method of measurement: amount of Hemoglobin drop. | — |
Secondary
| Measure | Time frame |
|---|---|
| Transfusion rate. Timepoint: Before the intervention, 24h after the intervention. Method of measurement: number of units of blood transfused. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Morteza Kazemi
Shahid Beheshti University of Medical Sciences
Outcome results
None listed